Caxton Associates (New York)’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$615K Buy
48,648
+790
+2% +$9.52K 0.02% 294
2024
Q3
$536K Buy
47,858
+22,581
+89% +$264K 0.02% 352
2024
Q2
$324K Buy
25,277
+2,485
+11% +$37.9K 0.01% 398
2024
Q1
$356K Sell
22,792
-43,411
-66% -$685K 0.02% 362
2023
Q4
$1.09M Buy
66,203
+38
+0.1% +$528 0.06% 214
2023
Q3
$798K Buy
66,165
+22,537
+52% +$303K 0.11% 187
2023
Q2
$621K Sell
43,628
-77,214
-64% -$1.13M 0.09% 227
2023
Q1
$1.87M Buy
120,842
+28,320
+31% +$458K 0.28% 58
2022
Q4
$1.61M Buy
92,522
+26,208
+40% +$389K 0.11% 67
2022
Q3
$846K Buy
66,314
+8,254
+14% +$110K 0.11% 147
2022
Q2
$659K Buy
+58,060
New +$551K 0.06% 204
2020
Q3
Sell
-16,804
Closed -$241K 308
2020
Q2
$241K Buy
+16,804
New +$246K 0.02% 325

Other funds holding OSG

Caxton Associates (New York)'s OSG Position: Q4 2024 in Review

Caxton Associates (New York) increased its Octave Specialty Group (OSG) stake by 1.7% in Q4 2024, buying an estimated $9.52K and bringing the position to 48,648 shares worth $615K. The position accounts for 0.02% of the portfolio, ranked #294.

Caxton Associates (New York) first reported a position in OSG in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.87M in Q1 2023. 180 funds tracked by Wall St. Rank hold OSG as of Q4 2024.

  • Caxton Associates (New York) held 48,648 shares of Octave Specialty Group worth $615K as of Q4 2024.
  • Caxton Associates (New York) bought 790 Octave Specialty Group shares in Q4 2024, an estimated $9.52K.
  • Octave Specialty Group made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #294 holding.
  • Caxton Associates (New York) first reported a position in Octave Specialty Group in Q2 2020 and has held it in 12 quarters since.
  • Caxton Associates (New York)'s Octave Specialty Group position peaked at $1.87M in Q1 2023.
  • 180 funds tracked by Wall St. Rank held Octave Specialty Group as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.